Filing Details

Accession Number:
0000899243-15-004744
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-14 16:30:27
Reporting Period:
2015-09-10
Filing Date:
2015-09-14
Accepted Time:
2015-09-14 16:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042418 Hedgepath Pharmaceuticals Inc. HPPI Services-Commercial Physical & Biological Research (8731) 541641133
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1066040 Jr E Francis Odonnell 324 S. Hyde Park Avenue, Suite 350
Tampa FL 33606
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.0001 Par Value Per Share Acquisiton 2015-09-10 20,000,000 $0.00 20,000,000 No 4 P Indirect By Hopkins Capital Group II, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Hopkins Capital Group II, LLC
Footnotes
  1. On the September 10, 2015, Hedgepath, LLC transferred 20,000,000 shares of common stock to Hopkins Capital Group II, LLC ("HCGII") in satisfaction of $1,577,797.54 in then outstanding debt.
  2. The shares are owned by HCGII. The Reporting Person is the co-manager of HCGII. Filing of this statement shall not be deemed an admission by the Reporting Person that he beneficially owns the securities held by HCGII. The Reporting Person disclaims ownership of all securities held by HCGII.